Sale!

CYP2B6 Gene Efavirenz poor metabolism of Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The CYP2B6 Gene Efavirenz Poor Metabolism Genetic Test is a specialized diagnostic assessment available at DNA Labs UAE, designed to evaluate an individual’s ability to metabolize Efavirenz, a medication commonly used in the treatment of HIV. This test focuses on analyzing the CYP2B6 gene, which plays a critical role in the metabolism of Efavirenz. Variations in this gene can lead to poor metabolism of the drug, potentially resulting in suboptimal treatment outcomes or increased side effects.

Understanding an individual’s genetic predisposition to metabolize Efavirenz can help healthcare providers tailor medication regimens that are more effective and have fewer side effects, leading to improved patient care. The test is priced at 4400 AED and is conducted in the state-of-the-art facilities of DNA Labs UAE, ensuring accurate and reliable results. This genetic testing is a valuable tool for personalized medicine, offering insights that can significantly impact the management of HIV treatment.

Description

CYP2B6 Gene Efavirenz Poor Metabolism of Genetic Test

Test Name: CYP2B6 Gene Efavirenz Poor Metabolism of Genetic Test

Components: Blood or Extracted DNA or One drop Blood on FTA Card

Price: 4400.0 AED

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Metabolic Disorders

Doctor: General Physician

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for CYP2B6 Gene Efavirenz, poor metabolism of NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with Efavirenz, poor metabolism of.

Test Details:

The CYP2B6 gene is responsible for encoding the cytochrome P450 2B6 enzyme, which plays a crucial role in the metabolism of various drugs, including efavirenz. Efavirenz is an antiretroviral medication commonly used in the treatment of HIV/AIDS.

Some individuals may have genetic variations in the CYP2B6 gene that result in poor metabolism of efavirenz. This can lead to higher drug concentrations in the blood, potentially increasing the risk of adverse effects or toxicity.

To determine an individual’s genetic variation in the CYP2B6 gene, a Next-Generation Sequencing (NGS) genetic test can be performed. NGS is a high-throughput sequencing technology that allows for the simultaneous analysis of multiple genes or the entire genome.

NGS genetic testing can identify specific genetic variants in the CYP2B6 gene that are associated with poor metabolism of efavirenz. This information can be used to personalize the dosage of efavirenz or consider alternative treatment options to minimize the risk of adverse effects.

It is important to note that the interpretation of genetic test results should always be done by a qualified healthcare professional who can consider other factors, such as the individual’s overall health and other medications they may be taking.

Test Name	CYP2B6 Gene Efavirenz poor metabolism of Genetic Test
Components
Price	4400.0 AED
Sample Condition	Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery	3 to 4 Weeks
Method	NGS Technology
Test type	Metabolic Disorders
Doctor	General Physician
Test Department:	Genetics
Pre Test Information	Clinical History of Patient who is going for CYP2B6 Gene Efavirenz, poor metabolism of NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with Efavirenz, poor metabolism of
Test Details	The CYP2B6 gene is responsible for encoding the cytochrome P450 2B6 enzyme, which plays a crucial role in the metabolism of various drugs, including efavirenz. Efavirenz is an antiretroviral medication commonly used in the treatment of HIV/AIDS. Some individuals may have genetic variations in the CYP2B6 gene that result in poor metabolism of efavirenz. This can lead to higher drug concentrations in the blood, potentially increasing the risk of adverse effects or toxicity. To determine an individual’s genetic variation in the CYP2B6 gene, a Next-Generation Sequencing (NGS) genetic test can be performed. NGS is a high-throughput sequencing technology that allows for the simultaneous analysis of multiple genes or the entire genome. NGS genetic testing can identify specific genetic variants in the CYP2B6 gene that are associated with poor metabolism of efavirenz. This information can be used to personalize the dosage of efavirenz or consider alternative treatment options to minimize the risk of adverse effects. It is important to note that the interpretation of genetic test results should always be done by a qualified healthcare professional who can consider other factors, such as the individual’s overall health and other medications they may be taking.